Cargando…
Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946874/ https://www.ncbi.nlm.nih.gov/pubmed/29020320 http://dx.doi.org/10.1093/eurheartj/ehx547 |
Ejemplares similares
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
por: Escaned, Javier, et al.
Publicado: (2017) -
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study
por: Banning, Adrian P, et al.
Publicado: (2021) -
Residual SYNTAX score II: A combination of the assessment of the revascularization degree and the clinical evaluation after percutaneous coronary intervention
por: Boukhris, Marouane, et al.
Publicado: (2018) -
Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling
por: Gamrekelashvili, Jaba, et al.
Publicado: (2017) -
Risk Stratification by SYNTAX Score Systems in Current Percutaneous Revascularization Era
por: Kim, Choongki
Publicado: (2019)